| Followers | 65 |
| Posts | 10174 |
| Boards Moderated | 0 |
| Alias Born | 03/29/2015 |
Wednesday, May 17, 2017 8:03:41 PM
Ahistoricity is worse than innumeracy. NWBO uplisted before and in the long run it made things far worse.
If NWBO leadership behaves like they are running a penny stock then potential investors will correctly continue to value and treat them accordingly, whether or not they are listed on a major exchange.
Unless NWBO is willing to clearly admit their mistakes and then concretely and consistently make real reforms to their corporate governance and business model to better protect shareholder value, there is no point in enduring an reverse split to earn an advantage (being on the NASDAQ) which we all saw them squander in slow motion even as many of us begged them to stop.
NWBO needs to increase its share price legitimately (as Les Goldman once suppposedly said they would do) and not via cheap and unsustainable mathematical tricks.
If NWBO leadership behaves like they are running a penny stock then potential investors will correctly continue to value and treat them accordingly, whether or not they are listed on a major exchange.
Unless NWBO is willing to clearly admit their mistakes and then concretely and consistently make real reforms to their corporate governance and business model to better protect shareholder value, there is no point in enduring an reverse split to earn an advantage (being on the NASDAQ) which we all saw them squander in slow motion even as many of us begged them to stop.
NWBO needs to increase its share price legitimately (as Les Goldman once suppposedly said they would do) and not via cheap and unsustainable mathematical tricks.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
